Intensification of antibiotic use within acute care hospitals in the Netherlands

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 9, 2012, Pages 2283-2288

  Kwint, H M ^a,b   Van der linden, P D ^c   Roukens, M M B ^a   Natsch, S ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GELDERSE VALLEI HOSPITAL   (Netherlands)

^c Tergooi Ziekenhuizen ^*  (Netherlands)

Author keywords

Dutch; In patient use; Inhabitants; Length of stay

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; FLUCLOXACILLIN; FUSIDIC ACID; GENTAMICIN; MEROPENEM; METRONIDAZOLE; NITROFURANTOIN; NORFLOXACIN; PENICILLIN G; PHENETICILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; DRUG USE; GENERAL HOSPITAL; HOSPITAL CARE; HOSPITAL PHARMACY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; NETHERLANDS; QUESTIONNAIRE; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; HOSPITALS, GENERAL; HOSPITALS, TEACHING; HOSPITALS, UNIVERSITY; HUMANS; NETHERLANDS; QUESTIONNAIRES;

EID: 84865370107     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks190     Document Type: Article

References (21)

1. SWAB (Dutch Working Party on Antibiotic Policy). Stichting Werkgroep Antibiotica Beleid. http://www.swab.nl (29 December 2011, date last accessed).
2. Janknegt R, Oude LA, Gould IM et al. Antibiotic use in Dutch hospitals 1991-1996. J Antimicrob Chemother 2000; 45: 251-6.
3. Liem TB, Filius FM, van der Linden PD et al. Changes in antibiotic use in Dutch hospitals over a six-year period: 1997 to 2002. Neth J Med 2005; 63: 354-60.
4. SWAB (Dutch Working Party on Antibiotic Policy). NethMap 2011- Consumption of Antimicrobial Agents and Antimicrobial Resistance among Medically Important Bacteria in the Netherlands. http://www. swab.nl/nethmap (29 December 2011, date last accessed).
5. Filius PM, Liem TB, van der Linden PD et al. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother 2005; 55: 805-8.
6. Vander Stichele RH, Elseviers MM, Ferech M et al. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006; 58: 159-67.
7. STZ (Association of Tertiary Medical Teaching Hospitals). Topklinische Ziekenhuizen Nederland. http://www.stz-ziekenhuizen.nl (29 December 2011, date last accessed).
8. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs 2010. Oslo, Norway: WHO Collaborating Centre, 2011. www. whocc.no (29 December 2011, date last accessed).
9. CBS (Statistics Netherlands). Bevolking; Generatie, Geslacht, Leeftijd en Herkomstgroepering, 1 Januari. http://statline.cbs.nl (29 December 2011, date last accessed).
10. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2011. http://www.R-project.org/ (29 December 2011, date last accessed).
11. Ansari F, Molana H, Goossens H et al. Development of standardized methods for analysis of changes in antibacterial use in hospitals from European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000-06. J Antimicrob Chemother 2010; 65: 2685-91.
12. Vander Stichele RH, Elseviers MM, Ferech M et al. European Surveillance of Antimicrobial Consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol 2004; 58: 419-28.
13. Kern WV, Steib-Bauert M, With K. Comment on: Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006; 58: 900-1.
14. Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 2007; 65 Suppl 2: 50-4.
15. Hayden MK, Bonten MJ, Blom DW et al. Reduction in acquisition of vancomycin-resistant Enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006; 42: 1552-60.
16. Kohlenberg A, Brummer S, Higgins PG et al. Outbreak of carbapenemresistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J Med Microbiol 2009; 58: 1499-507.
17. Lu PL, Huang LY, Lian ST et al. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital. Int J Antimicrob Agents 2008; 31: 463-6.
18. Ong DS, Jongerden IP, Buiting AG et al. Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units. Crit Care Med 2011; 39: 2458-63.
19. Goorhuis A, Bakker D, Corver J et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47: 1162-70.
20. Wertheim HF, Vos MC, Boelens HA et al. Low prevalence of methicillinresistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 2004; 56: 321-5.
21. Lekkerkerk WS, van de Sande-Bruinsma N, van der Sande MA et al. Emergence of MRSA of unknown origin in the Netherlands. Clin Microbiol Infect 2011; doi:10.1111/j.1469-0691.2011.03662.x.